Herpes Zoster
📧 Sign up to get email alerts when something new happens for Herpes Zoster.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: Multimodal Nerve Block and Pulse Radiofrequency for Acute Herpes Zoster Pain [NA]
This clinical trial investigates multimodal nerve block combined with pulse radiofrequency to treat acute herpes zoster pain. The study stat…
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: Predicting Ultrasound-Guided Thoracic PVB Success in Herpetic Neuralgia [NA]
A study from Beni-Suef University is recruiting to predict the success of ultrasound-guided thoracic paravertebral block in patients with po…
-
CLINICAL_TRIALS trial_result · 2024-12-30Clinical Trial Update: Rhomboid Intercostal and Subserratus Plane Block Versus Paravertebral Block for Thoracic Herpes Zoster [NA]
A completed clinical trial comparing rhomboid intercostal and subserratus plane block with paravertebral block for thoracic herpes zoster.
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of ChAdOx1-VZV in Healthy Adults Aged 50-65 Years [Phase 1]
Phase 1 study evaluating the safety and immunogenicity of the ChAdOx1-VZV vaccine in healthy adults aged 50-65 has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Immunogenicity and Safety of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 30 Years and Above [Phase 2]
Phase 2 clinical trial update evaluating the immunogenicity and safety of a recombinant CHO cell–derived herpes zoster vaccine in healthy ad…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Safety and Immunogenicity of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 18 Years and Above [Phase 1]
A Phase 1 trial evaluating the safety and immunogenicity of MAXVAX's recombinant herpes zoster vaccine produced in CHO cells in healthy adul…
-
CLINICAL_TRIALS other · 2024-11-20Clinical Trial Update: Phase III Clinical Trial of Lot-to-lot Consistency of Recombinant Herpes Zoster Vaccine (CHO Cell). [Phase 3]
Phase III trial to evaluate lot-to-lot consistency of MAXVAX's recombinant herpes zoster vaccine produced in CHO cells; status is NOT_YET_RE…
-
CLINICAL_TRIALS research · 2024-11-19Clinical Trial Update: Safety and Immunogenicity of CVI-VZV-001 for Prevention of Herpes Zoster in Healthy Adults Age 50 Years and Above [Phase 1]
Phase 1 clinical trial evaluating safety and immunogenicity of CVI-VZV-001 for herpes zoster prevention in adults 50 and older; recruitment …
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Vitamin C as add-on Therapy in Patients With Acute Herpes Zoster [Phase 2]
A Phase 2 trial evaluating add-on vitamin C for acute herpes zoster has been terminated.
-
CLINICAL_TRIALS research · 2024-10-31Clinical Trial Update: Impact on Quality of Life and Burden of Disease in Adults With Herpes Zoster
A clinical trial protocol evaluating how herpes zoster affects quality of life and disease burden in adults, with recruitment not yet underw…
-
CLINICAL_TRIALS research · 2024-10-24Clinical Trial Update: Efficacy, Safety and Immunogenicity Study of Recombinant Zoster Vaccine(CHO Cell) in Adults Aged 40 Years and Older [Phase 3]
This clinical trial update describes a Phase 3 study evaluating the efficacy, safety and immunogenicity of a Recombinant Zoster Vaccine (CHO…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Persistence of Protection by Shingrix [Phase 4]
Phase 4 trial updates show persistence of protection from Shingrix against herpes zoster; results have been posted.
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Obesity and Obesity-Related Factors and Risk of Herpes Zoster (Shingles) and Postherpetic Neuralgia
The study investigates whether obesity and related factors influence the risk of herpes zoster and postherpetic neuralgia. It is currently a…
-
CLINICAL_TRIALS research · 2024-09-27Clinical Trial Update: Multidisciplinary Hospital-Territory Vaccine Center: a Model for Achieving the Herpes Zoster Vaccine Coverage
A completed clinical trial update describes a multidisciplinary hospital-territory vaccine center model aimed at increasing herpes zoster va…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine and Assessment of 1 or 2 Additional Doses in Two Subgroups of Older Adults [Phase 3]
This long-term follow-up analysis from two Phase 3 studies evaluates the durability of efficacy, safety, and immunogenicity of GSK's Herpes …
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster Vaccine [Phase 1]
A first-in-human Phase 1 study of JCXH-105, an srRNA-based vaccine for herpes zoster (shingles), has completed its Phase 1 evaluation.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Efficacy, Immunogenicity and Safety Study of GSKs Recombinant Zoster Vaccine Shingrix (GSK1437173A) in Chinese Adults Aged ≥50 Years [Phase 4]
Phase 4 trial evaluating efficacy, immunogenicity, and safety of Shingrix in Chinese adults aged 50 and older; results have been posted.
-
CLINICAL_TRIALS research · 2024-08-26Clinical Trial Update: Risk Factors of Anxiety and Depression in Patients With Herpes Zoster Neuralgia
This ClinicalTrials.gov entry describes an ongoing study from Huazhong University of Science and Technology investigating risk factors for a…
-
CLINICAL_TRIALS trial_result · 2024-08-06Clinical Trial Update: Shingrix in Patients With Rheumatic Diseases: a Double-blind Placebo-controlled RCT [Phase 4]
Phase 4 double-blind, placebo-controlled randomized trial evaluating Shingrix in patients with rheumatic diseases; the study is not yet recr…
-
CLINICAL_TRIALS research · 2024-06-27Clinical Trial Update: Ultrasound Guided Serratus Anterior Versus Erector Spinae Block in Pain Alleviation in Acute Herpes Zoster [NA]
A clinical trial comparing ultrasound-guided serratus anterior plane block versus erector spinae plane block for pain relief in acute herpes…
-
FDA approval · 2024-06-25FDA Approved: ACYCLOVIR — Original Application (Fresenius Kabi USA, LLC)
FDA approved the original application for a generic acyclovir product by Fresenius Kabi USA, LLC. This allows marketing of the generic antiv…
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: Simultaneous RZV and aIIV4 Vaccination [Phase 4]
Phase 4 trial by Duke University evaluating simultaneous administration of the recombinant zoster vaccine with an adjuvanted quadrivalent in…
-
CLINICAL_TRIALS trial_result · 2024-04-08Clinical Trial Update: A Study on the Immune Response and Safety of a Vaccine Against Herpes Zoster in Adults Aged 50 Years and Older in India [Phase 3]
Phase 3 trial in adults aged 50 years and older in India evaluating the immune response and safety of a herpes zoster vaccine; results have …
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: A Study on the Long-term Efficacy, Safety and Persistence of Immune Response of a Vaccine Against Herpes Zoster in Older Adults [Phase 3]
A Phase 3 trial update assessing long-term efficacy, safety, and persistence of immune response for a herpes zoster vaccine in older adults.
-
FDA approval · 2024-01-08FDA Approved: ACYCLOVIR — Original Application (Slate Run Pharmaceuticals, LLC)
The FDA approved the original ANDA for acyclovir from Slate Run Pharmaceuticals, LLC, authorizing a generic acyclovir product. This marks re…